| Connect to share and comment |
Alexander BesantMay 19, 2012 22:48
Stem cell drug approved in Canada to treat bone marrow disease
The drug, Prochymal, will be used to treat a deadly side effect of bone marrow transplants called acute graft-versus host disease, which occurs in children.
The drug, Prochymal, will be used to treat a deadly side effect of bone marrow transplants called acute graft-versus host disease, which occurs in children.
Enlarge
Canadian regulators approve the first drug containing stem cells. (Spencer Platt/Getty Images)
Canadian regulators have approved the world's first stem cell drug.
The drug, Prochymal, will be used to treat a deadly side effect of bone marrow transplants called acute graft-versus host disease (GvHD), which occurs in children.
Acute graft-versus host disease kills about 80 percent of children affected.
Prochymal uses stem cells from healthy adult donors, with one donation able to create 10,000 doses of the drug, reported the New York Times.
The manufacturer, Maryland-based Osiris Therapeutics Inc., saw their shares climb 5.5 percent to $5.55 after losing 24 percent in the last year, reported Bloomberg.
In extended trading, stocks rose 14 percent.
The drug was approved, said Reuters, on the condition that further clinical tests are carried out.
There has been debate about the effectiveness of the drug in recent years.
Late stage clinical trials three years ago failed to show results but more recent tests have shown the drug to be relatively effective about a month into therapy.
Osiris says that it plans to seek approval from the US Food and Drug Administration this year.
http://www.globalpost.com/dispatch/news/health/120519/stem-cell-drug-approved-canada-treat-bone-marrow-transplant-symptoms
.
-
Photo
Jaume Plensa's "Tel Aviv Man" at Art Basel, the world’s premier trade fair for leading galleries and collectors focused on modern and contemporary art.
- [/] -
Photo
The front of the Art Basel building. This year’s show attracted 303 of the world’s top galleries from 36 countries, showing the works of more than 2,500 artists. It drew more than 62,000 visitors, a new record.
- [/] -
Photo
Platform Gallery's Chen Wei and one of his "Recovery Room" series at Liste Young Artist's show. By the time the week was over he had sold more than 10 works, with prices ranging from $1,800 to nearly $3,000.
- [/] -
Photo
A performance spectator admires some of the pieces at Basel Art.
- [/] -
Photo
A performance piece at Basel Scope, done by an unidentified nearly naked man who moved in slow motion up and down the aisles dressed like a Greek version of Mars, the god of war.
- [/] -
Photo
A performance piece at Scope. The man clutched a staff, on which a plastic container for motor oil with the BP logo was impaled.
- [/] -
Photo
An installation piece at Basel Art.
- [/] -
Photo
An installation piece with paper tubes at Basel Art.
- [/] -
Photo
A gallery scene at the Scope Basel show.
- [/] -
Photo
A sculpture of Sperone Westwater Gallery's employee, Michael Short, by Evan Penny.
- [/] -
Photo
Evan Penny's sculpture of Michael Short.
- [/] -
Photo
A woman views Jaume Plensa's "Tel Aviv Man," (Study) 2010, Galerie Lelong, Paris.
- [/] -
Photo
"Medusa marinara," 1997 — a photographic representation of the Medusa in spaghetti and tomato sauce by New York-based Brazilian artist, Vic Muniz.
- [/] -
Photo
Children play around Ai Weiwei's piece, "Field," 2010.
- [/] -
Photo
Heimo Sobernig's "Black Cube" sits on display outside outside.
- [/] -
Photo
A piece by Yayoi Kusama titled "Pumkin."
- [/]
Follow us: